Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 23, 2004 02:09 ET | Source: Crucell N.V.

Crucell Secures Euro 2 Million Grant for Malaria Collaboration from Dutch Ministry of Economic Affairs

LEIDEN, The Netherlands, Dec. 23, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that it has received a grant of up to Euro 2 Million from...
December 22, 2004 02:07 ET | Source: Crucell N.V.

Crucell Announces Second PER.C6(R) License Agreement with Chiron

LEIDEN, The Netherlands, Dec. 22, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) today announced that it has signed a second PER.C6(R) license agreement...
December 16, 2004 02:10 ET | Source: Crucell N.V.

CEVEC Acknowledges Crucell Claims in Patent Infringement Hearing

LEIDEN, The Netherlands, Dec. 16, 2004 (PRIMEZONE) -- In the patent infringement action initiated by Crucell (Nasdaq:CRXL) against CEVEC Pharmaceuticals GmbH, the German Dusseldorf District Court...
December 15, 2004 08:20 ET | Source: Crucell N.V.

Crucell Announces Milestone Achievement in Merck's PER.C6(R)-related Investigational HIV Vaccine Program

LEIDEN, Netherlands, Dec. 15, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Merck & Co., Inc. (NYSE:MRK) has met a clinical...
November 30, 2004 10:50 ET | Source: Crucell N.V.

Crucell Candidate for Amsterdam Midkap Index on Euronext

LEIDEN, Netherlands, Nov. 30, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been selected by Euronext Indices B.V. (Euronext)...
November 30, 2004 02:06 ET | Source: Crucell N.V.

Graham Dixon joins Galapagos as Chief Scientific Officer

MECHELEN, Belgium and LEIDEN, The Netherlands, Nov. 30, 2004 (PRIMEZONE) -- Galapagos announced today that Graham Dixon has been appointed Chief Scientific Officer (CSO). Dr. Dixon will be...
November 24, 2004 02:33 ET | Source: Crucell N.V.

Crucell Announces PER.C6 Licensing Agreement with Edwards Lifesciences

LEIDEN, The Netherlands, Nov. 24, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a PER.C6(r) research license agreement...
November 19, 2004 02:08 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6 Licensing Agreement with Micromet for Monoclonal Antibody Production

LEIDEN, The Netherlands, Nov. 19, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they...
November 18, 2004 07:10 ET | Source: Crucell N.V.

Celgene and Galapagos Enter Target Discovery Collaboration

WARREN, N.J. and MECHELEN, Belgium and LEIDEN, The Netherlands (PRIMEZONE) -- Celgene (Nasdaq:CELG), a leading global biopharmaceutical company with focus on the discovery, development and...
November 16, 2004 11:56 ET | Source: Crucell N.V.

Crucell Discovers and Validates Human Monoclonal Antibody Product that Protects Against Rabies in Collaboration with CDC and TJU

LEIDEN, Netherlands, Nov. 16, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today the discovery and preclinical validation of an effective...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right